US quartet snatches jobs on $2.6bn pharmaceuticals purchase
US firms Latham & Watkins, Skadden Arps Meagher & Flom, Sullivan & Cromwell and Weil Gotshal & Manges have all won roles advising on Valeant Pharmaceuticals’ $2.6bn (£1.6bn) acquisition of dermatology drugmaker Medicis Pharmaceutical. The terms of the deal see Valeant, the Canadian publicly-traded drugmaker, pay $44 (£28) per share in cash for US-based Medicis. […]